Vestal Point Capital’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-645,000
Closed -$3.64M 83
2024
Q4
$3.64M Buy
645,000
+120,000
+23% +$677K 0.22% 59
2024
Q3
$2.54M Buy
525,000
+25,000
+5% +$121K 0.19% 59
2024
Q2
$2.44M Buy
+500,000
New +$2.44M 0.18% 53